Candy Steed

Candy Steed is a seasoned professional in the field of molecular oncology, currently serving as a Molecular Oncology Specialist at Caris Life Sciences since January 2021. Prior to this role, Candy worked as an Account Executive at Guardant Health from October 2017 to January 2021 and as an Oncology Product Specialist at Myriad Genetics from June 2009 to January 2017, focusing on hereditary cancer testing and engagement with oncologists, surgeons, and gastroenterologists across West Virginia. Candy's career began at Novartis, where sales experience included promoting cardiovascular and specialty products to various medical specialists from August 2001 to June 2009. Candy holds a Bachelor of Arts in Secondary Education and Teaching and a Master's degree in Biology, both from Marshall University.